![Lei Yang](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Lei Yang
Président chez Hubei Bafeng Pharmaceuticals & Chemicals Share Co., Ltd.
Profil
Lei Yang has held positions as Chairman at Hubei Bafeng Pharmaceuticals & Chemicals Share Co., Ltd.
and Member-Supervisory Board at Hubei Grand Life Science & Technology Co., Ltd.
Postes actifs de Lei Yang
Sociétés | Poste | Début |
---|---|---|
Hubei Grand Life Science & Technology Co., Ltd
![]() Hubei Grand Life Science & Technology Co., Ltd Pharmaceuticals: MajorHealth Technology Hubei Grand Life Science & Technology Co., Ltd. engages in the manufacture and distribution of pharmaceutical products. Its main products include taurine, taurine powder, theanine, thearine powder, and L-carnitine series. The company was founded in 1958 and is headquartered in Huangshi, China. | Directeur/Membre du Conseil | - |
Hubei Bafeng Pharmaceuticals & Chemicals Share Co., Ltd.
![]() Hubei Bafeng Pharmaceuticals & Chemicals Share Co., Ltd. Chemicals: Major DiversifiedProcess Industries Part of Grand Pharmaceutical Group Ltd., Hubei Bafeng Pharmaceuticals & Chemicals Share Co., Ltd. engages in the production and operation of amino acid API products. The company is based in Enshi, China. The Chinese company was founded in 1997. The CEO is Cheng Ping Cai. Hubei Bafeng Pharmaceuticals & Chemicals Share Co. was acquired by Grand Pharmaceutical Group Ltd. on September 27, 2022 for $39.99 million. | Président | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 2 |
---|---|
Hubei Grand Life Science & Technology Co., Ltd
![]() Hubei Grand Life Science & Technology Co., Ltd Pharmaceuticals: MajorHealth Technology Hubei Grand Life Science & Technology Co., Ltd. engages in the manufacture and distribution of pharmaceutical products. Its main products include taurine, taurine powder, theanine, thearine powder, and L-carnitine series. The company was founded in 1958 and is headquartered in Huangshi, China. | Health Technology |
Hubei Bafeng Pharmaceuticals & Chemicals Share Co., Ltd.
![]() Hubei Bafeng Pharmaceuticals & Chemicals Share Co., Ltd. Chemicals: Major DiversifiedProcess Industries Part of Grand Pharmaceutical Group Ltd., Hubei Bafeng Pharmaceuticals & Chemicals Share Co., Ltd. engages in the production and operation of amino acid API products. The company is based in Enshi, China. The Chinese company was founded in 1997. The CEO is Cheng Ping Cai. Hubei Bafeng Pharmaceuticals & Chemicals Share Co. was acquired by Grand Pharmaceutical Group Ltd. on September 27, 2022 for $39.99 million. | Process Industries |